Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • NCD 2025
NET Nurse
Donate

Home » Patient Stories » Vanessa, ACT

Vanessa, ACT

My name is Vanessa. I’m 34 years old, and I live in Canberra. I have Von Hippel-Lindau syndrome (VHL)—a rare genetic condition that causes tumours and cysts to grow throughout the body, often in places like the brain, spinal cord, kidneys, pancreas and eyes.

I was in my late twenties when I first realised something wasn’t right. I began experiencing numbness in my back, and after months of tests and uncertainty, doctors discovered a cluster of tumours in my spine. That’s when I was diagnosed with VHL.

It was a confronting moment—but not entirely unexpected. My father passed away from VHL when he was just 42, and my brother also lives with the condition. So in many ways, I grew up knowing what this disease could do. But facing it myself has been a completely different kind of challenge.

Since my diagnosis, I’ve had multiple surgeries—on my spine, my neck, and both of my kidneys. I’ve already lost my right kidney, and half of my left. With my kidney, if the current tumours grow too big, I will lose the remaining kidney and become dialysis dependent.

Hopefully, with the help of Belzutifan, it will help save both my pancreas and kidney, stopping me from ending up on dialysis and insulin for as long as possible.

Living with VHL means living with constant uncertainty. I undergo regular scans, always wondering if something new will show up. The burden isn’t just physical—it’s emotional, it’s mental, and it’s lifelong.

I’ve had to make heart breaking decisions, including accepting that I won’t be able to have children due to the risk the disease poses. VHL has touched nearly every part of my life—my health, my relationships, my ability to plan for the future. And yet, every day, I do my best to keep going.

There are moments of deep fear, but also moments of incredible gratitude—for the medical teams who look after me, for the support of my family, and for the progress that’s been made in understanding this disease.

Recently, I gained access to a new treatment that offers hope in managing VH (Belzutifan). It hasn’t erased the challenges, but it has helped me feel like I have a bit more control—like I have more time to live, not just survive.

I could still face the possibility of more surgeries but the likelihood is less. But now, I also have hope. And that’s something I haven’t always had.

For anyone living with a rare condition like VHL, I want to say: you are not alone. There is strength in speaking up, in connecting with others, and in sharing your story.

My journey is far from over. But today, I have the space to imagine a future—something as simple and powerful as planning a birthday or dreaming of travel. And that means everything.

Read Vanessa’s news article here.

Patient Stories

Dan, VIC

I know that I don’t have all the knowledge or tools in my kit to win the mental game by myself, so my family and I reach out to the amazing, experienced resources that are available at NeuroEndocrine Cancer Australia. It really helps to have someone that can validate how I am feeling or explain the processes and cycles that I will go through.

Karen, SA

My days and months have been spending time and money on and in medical appointments, tests and scans, rooms, clinics and medications and listening to profoundly specialised medical jargon, which is not always explained fully and sometimes assumed to be common knowledge,

Roxanne, ACT

The hardest thing has been actually finding out what was wrong with me. No-one could tell me for months and the toll it took on me and my family was devastating. The lack of knowledge of NETs amongst the medical fraternity amazed me. Still a long way to go.

Judy, SA

The results showed 15 tumours in my liver. Within days I had a biopsy, which confirmed it was a neuroendocrine tumour. I had never heard of this type of cancer prior to being diagnosed.

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin